arrow_back Trending Legislation
Share share

Glioblastoma Awareness Day: Support for Patients and Research

The U.S. House of Representatives supports designating July 16, 2025, as Glioblastoma Awareness Day. This aims to increase public understanding of this aggressive disease, honor those affected, and encourage further research into new treatments. Citizens will gain greater awareness of this rare but deadly disease, potentially fostering support for research initiatives and improved care.
Key points
Designation of July 16, 2025, as Glioblastoma Awareness Day to increase public awareness.
Support for developing better glioblastoma treatments to improve patient prognosis and quality of life.
Encouragement of continued investment in glioblastoma research, including through the Glioblastoma Therapeutics Network.
Recognition of the importance of molecular biomarker testing for glioblastoma diagnosis and treatment.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Introduced
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Expressing support for the designation of July 16, 2025, as "Glioblastoma Awareness Day".
Print number: HRES 394
Sponsor: Rep. Williams, Roger [R-TX-25]
Process start date: 2025-05-06
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Glioblastoma Awareness Day: Support for Patients and Research

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HRES 394.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-05-06.

What are the main provisions?

Key points include:

  • Designation of July 16, 2025, as Glioblastoma Awareness Day to increase public awareness.
  • Support for developing better glioblastoma treatments to improve patient prognosis and quality of life.
  • Encouragement of continued investment in glioblastoma research, including through the Glioblastoma Therapeutics Network.
  • Recognition of the importance of molecular biomarker testing for glioblastoma diagnosis and treatment.

What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Williams, Roger [R-TX-25].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-21.

Analysis and Potential Impact of HRES 394

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health